PharmaResources (China) Investor Sentiment

301230 Stock   27.00  0.62  2.24%   
About 62% of PharmaResources' investor base is looking to short. The analysis of the overall investor sentiment regarding PharmaResources Co Ltd suggests that many traders are alarmed. The current market sentiment, together with PharmaResources' historical and current headlines, can help investors time the market. In addition, many technical investors use PharmaResources stock news signals to limit their universe of possible portfolio assets.
  
over a week ago at news.google.com         
3 High Growth Stocks With Strong Insider Confidence - Yahoo Finance
Google News at Macroaxis
over two months ago at news.google.com         
Mankind Pharma Engages Kotak and IIFL for 3,000 Crore QIP to Fund BSV Acquisition - PUNE.NEWS
Google News at Macroaxis
over three months ago at news.google.com         
PharmaResources Second Quarter 2024 Earnings EPS CN0.093 - Simply Wall St
Google News at Macroaxis
over three months ago at news.google.com         
Chinese Growth Companies With High Insider Ownership For August 2024 - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
Clinical Trial Supplies Market size is set to grow by USD 1.31 billion from 2024-2028, Growth of bio...
Google News at Macroaxis
over six months ago at news.google.com         
PharmaResources Posted Weak Earnings But There Is More To Worry About - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
PharmaResources Full Year 2023 Earnings Misses Expectations - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
PHARMARESOURCES S Revenue Breakdown SZSE301230 TradingView - TradingView
Google News at Macroaxis
over six months ago at news.google.com         
PharmaResources Co., Ltd.s largest shareholders are private companies who were rewarded as market ca...
Google News at Macroaxis
over six months ago at news.google.com         
Detailed Sun Pharma analysis - Specialty Products, Revenue and more - Groww
Google News at Macroaxis
over a year ago at news.google.com         
Clinical Trial Supplies Market to grow by USD 1.19 billion from 2022 ... - Yahoo Finance
Google News at Macroaxis
over a year ago at news.google.com         
Global Pharmaceutical Grade Ticagrelor Market 2023 Growth factor ... - Wexford Echo
Google News at Macroaxis
over a year ago at news.google.com         
How AI and technology are redefining job roles and responsibilities in the Bio-pharma sector - The F...
Google News at Macroaxis
over a year ago at news.google.com         
PharmaResources - MassBio
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about PharmaResources that are available to investors today. That information is available publicly through PharmaResources media outlets and privately through word of mouth or via PharmaResources internal channels. However, regardless of the origin, that massive amount of PharmaResources data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of PharmaResources news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of PharmaResources relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to PharmaResources' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive PharmaResources alpha.

PharmaResources Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
3 High Growth Stocks With Strong Insider Confidence - Yahoo Finance
12/06/2024

Complementary Tools for PharmaResources Stock analysis

When running PharmaResources' price analysis, check to measure PharmaResources' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PharmaResources is operating at the current time. Most of PharmaResources' value examination focuses on studying past and present price action to predict the probability of PharmaResources' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PharmaResources' price. Additionally, you may evaluate how the addition of PharmaResources to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format